94 related articles for article (PubMed ID: 10436769)
1. Rofecoxib for osteoarthritis and pain.
Med Lett Drugs Ther; 1999 Jul; 41(1056):59-61. PubMed ID: 10436769
[No Abstract] [Full Text] [Related]
2. Rofecoxib.
Scott LJ; Lamb HM
Drugs; 1999 Sep; 58(3):499-505; discussion 506-7. PubMed ID: 10493277
[TBL] [Abstract][Full Text] [Related]
3. Severe upper gastrointestinal bleeding during treatment with rofecoxib for osteoarthritis.
Caroli A; Monica F
Am J Gastroenterol; 2001 May; 96(5):1663-5. PubMed ID: 11374736
[No Abstract] [Full Text] [Related]
4. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).
Wynn RL
Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547
[No Abstract] [Full Text] [Related]
5. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
[TBL] [Abstract][Full Text] [Related]
6. Patient empowerment: rofecoxib revisited.
Tannenbaum H
J Rheumatol; 2006 Jun; 33(6):1033-5. PubMed ID: 16755647
[No Abstract] [Full Text] [Related]
7. COX-2 inhibitors: new drugs for the management of pain and inflammation.
Hutchins V; Hutchins B
Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
[No Abstract] [Full Text] [Related]
8. Rofecoxib: new preparation. A disappointing NSAID analgesic.
Prescrire Int; 2000 Dec; 9(50):166-7, 169. PubMed ID: 11475491
[TBL] [Abstract][Full Text] [Related]
9. COX-2 inhibitors.
Brooks PM; Day RO
Med J Aust; 2000 Oct; 173(8):433-6. PubMed ID: 11090038
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
Schnitzer TJ; Weaver AL; Polis AB; Petruschke RA; Geba GP;
J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs in orofacial pain management--an update.
van der Bijl P; van der Bijl P
SADJ; 2002 Aug; 57(8):328-31. PubMed ID: 12428528
[No Abstract] [Full Text] [Related]
12. Precision of composite measures of osteoarthritis efficacy in comparison to that of individual endpoints.
Bolognese JA; Ehrich EW; Schnitzer TJ
J Rheumatol; 2001 Dec; 28(12):2700-4. PubMed ID: 11764220
[TBL] [Abstract][Full Text] [Related]
13. Results from a patient survey to assess gastrointestinal burden of non-steroidal anti-inflammatory drug therapy contrasted with a review of data from EVA to determine satisfaction with rofecoxib.
Steinfeld S; Bjørke PA
Rheumatology (Oxford); 2002 Apr; 41 Supp 1():23-7; discussion 35-42. PubMed ID: 12173277
[TBL] [Abstract][Full Text] [Related]
14. Arthritis: what it is, why you get it and how to stop the pain.
Adler J
Newsweek; 2001 Sep; 138(10):38-46. PubMed ID: 11550612
[No Abstract] [Full Text] [Related]
15. Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors, in postoperative dental pain: a randomized, placebo- and active-comparator-controlled clinical trial.
Malmstrom K; Daniels S; Kotey P; Seidenberg BC; Desjardins PJ
Clin Ther; 1999 Oct; 21(10):1653-63. PubMed ID: 10566562
[TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenase-2 enzyme inhibitors: place in therapy.
Noble SL; King DS; Olutade JI
Am Fam Physician; 2000 Jun; 61(12):3669-76. PubMed ID: 10892637
[TBL] [Abstract][Full Text] [Related]
17. Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial.
Gibofsky A; Williams GW; McKenna F; Fort JG
Arthritis Rheum; 2003 Nov; 48(11):3102-11. PubMed ID: 14613272
[TBL] [Abstract][Full Text] [Related]
18. [Already the drug of choices in the USA. Coxibe in joint pain].
MMW Fortschr Med; 2002 Aug; 144(31-32):53. PubMed ID: 12422738
[No Abstract] [Full Text] [Related]
19. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Weir MR; Sperling RS; Reicin A; Gertz BJ
Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
[TBL] [Abstract][Full Text] [Related]
20. [COX-2 inhibitor in arthrosis. Discontinuation before operations not necessary].
MMW Fortschr Med; 2001 Oct; 143(42):64. PubMed ID: 11697296
[No Abstract] [Full Text] [Related]
[Next] [New Search]
